Healthcare Industry News: McNeil
News Release - January 18, 2007
James T. Lenehan Elected to Medtronic Board of Directors
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE:MDT ), today announced the election to its Board of Directors of James T. Lenehan, former Vice Chairman and President of Johnson & Johnson. Mr. Lenehan, who retired from Johnson & Johnson in 2004 after 28 years with the company, held various executive positions, including President of McNeil Consumer Products Company; Worldwide Chairman, Consumer Pharmaceuticals & Professional Group; and Worldwide Chairman, Medical Devices & Diagnostics Group. He was appointed to the Johnson & Johnson Executive Committee in 1994. Mr. Lenehan is currently a private investment consultant and serves as an advisor to Cerberus Capital Partners.Art Collins, Medtronic chairman and chief executive officer, noted that Lenehan has an extensive background in a broad range of medical products including medical devices that will be extremely valuable to Medtronic.
"We are delighted that Jim is joining the Medtronic board, bringing with him a wealth of expertise that will be very beneficial," Collins said. "Executives with Jim's qualifications are in great demand to serve on corporate boards, and the shareholders of Medtronic will be well served by his contributions."
About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 28, 2006. Actual results may differ materially from anticipated results.
Source: Medtronic
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
Related News Items
Medtronic Announces Positive Results From Real-World Registries For The Sphere-9(TM) Catheter and PulseSelect(TM) PFA System at APHRS 2026Medtronic Announces FDA Clearance for LigaSure(TM) RAS Maryland Instrument on the Hugo(TM) RAS System
Medtronic Announces Strategic Investments to Support Future Expansion of Cardiac Ablation Portfolio as Physician Demand for Affera(TM) Technologies Broadens
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!